Goldman Sachs’s SQZ Biotechnologies Company SQZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,896
| Closed | -$4.29K | – | 5123 |
|
|
2023
Q2 | $4.29K | Buy |
15,896
+1,012
| +7% | +$273 | ﹤0.01% | 4848 |
|
|
2023
Q1 | $8.34K | Sell |
14,884
-3,316
| -18% | -$1.86K | ﹤0.01% | 4973 |
|
|
2022
Q4 | $13.5K | Sell |
18,200
-7,595
| -29% | -$5.62K | ﹤0.01% | 4923 |
|
|
2022
Q3 | $58K | Sell |
25,795
-22,231
| -46% | -$50K | ﹤0.01% | 5019 |
|
|
2022
Q2 | $152K | Buy |
48,026
+18,634
| +63% | +$59K | ﹤0.01% | 4988 |
|
|
2022
Q1 | $141K | Sell |
29,392
-14,047
| -32% | -$67.4K | ﹤0.01% | 5203 |
|
|
2021
Q4 | $388K | Buy |
43,439
+8,449
| +24% | +$75.5K | ﹤0.01% | 4655 |
|
|
2021
Q3 | $505K | Buy |
34,990
+1,014
| +3% | +$14.6K | ﹤0.01% | 4370 |
|
|
2021
Q2 | $491K | Buy |
33,976
+8,545
| +34% | +$123K | ﹤0.01% | 4447 |
|
|
2021
Q1 | $348K | Buy |
25,431
+5,197
| +26% | +$71.1K | ﹤0.01% | 4557 |
|
|
2020
Q4 | $586K | Buy |
+20,234
| New | +$586K | ﹤0.01% | 3734 |
|